Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Alpine Immune Sciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- −3 vs. Q4 2022
- Shares held
- 41.4M
- +454.1K (+1.1%) vs. Q4 2022
- Total value
- $319.4M
- +$18.6M (+6.2%) vs. Q4 2022
- New holders
- 5
- 26 more added
- Sold out
- 8
- 13 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 180 | $2.56B |
| Q4 2023 | 133 | $1.12B |
| Q3 2023 | 88 | $525.8M |
| Q2 2023 | 77 | $449.3M |
| Q1 2023 | 61 | $319.4M |
| Q4 2022 | 64 | $300.8M |
| Q3 2022 | 70 | $284.0M |
| Q2 2022 | 58 | $204.4M |
| Q1 2022 | 56 | $221.8M |
| Q4 2021 | 53 | $257.1M |
| Q3 2021 | 44 | $163.5M |
| Q2 2021 | 47 | $118.5M |
| Q1 2021 | 48 | $145.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Alpine Immune Sciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 12 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 85 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 523 | $4.04K | 0.00% | −71−12.0% | Reduced |
| Metropolitan Life Insurance Co | 537 | $4.15K | 0.00% | −881−62.1% | Reduced |
| China Universal Asset Management Co., Ltd. | 623 | $4.81K | 0.00% | +156+33.4% | Added |
| FMR LLC | 1,256 | $9.70K | 0.00% | +576+84.7% | Added |
| Royal Bank of Canada | 1,327 | $10.0K | 0.00% | −1,828−57.9% | Reduced |
| Tower Research Capital LLC (TRC) | 1,499 | $12.0K | 0.00% | +478+46.8% | Added |
| Ameritas Investment Partners, Inc. | 1,900 | $14.7K | 0.00% | +989+108.6% | Added |
| Legal & General Group Plc | 2,473 | $19.1K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 2,833 | $22.0K | 0.00% | +448+18.8% | Added |
| Wells Fargo & Company | 4,392 | $33.9K | 0.00% | +4,392 | New |
| New York State Common Retirement Fund | 5,505 | $42.5K | 0.00% | +68+1.3% | Added |
| UBS Group AG | 7,993 | $61.7K | 0.00% | +5,717+251.2% | Added |
| California State Teachers Retirement System | 8,796 | $67.9K | 0.00% | −242−2.7% | Reduced |
| Susquehanna International Group, LLP | 10,634 | $82.1K | 0.00% | −11,528−52.0% | Reduced |
| American International Group, Inc. | 11,418 | $88.1K | 0.00% | +708+6.6% | Added |
| SG Americas Securities, LLC | 11,927 | $92.0K | 0.00% | +11,927 | New |
| Western Wealth Management, LLC | 12,000 | $92.6K | 0.01% | 00.0% | Unchanged |
| MetLife Investment Management | 12,028 | $92.9K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 12,079 | $93.3K | 0.00% | +5,999+98.7% | Added |
| Hikari Power Ltd | 12,445 | $96.0K | 0.01% | 00.0% | Unchanged |
| Deutsche Bank AG | 14,751 | $113.9K | 0.00% | +6,596+80.9% | Added |
| Price T Rowe Associates Inc | 19,625 | $152.0K | 0.00% | +224+1.2% | Added |
| BNP Paribas Arbitrage, SA | 20,518 | $158.4K | 0.00% | +5,007+32.3% | Added |
| Bank of America Corp | 23,500 | $181.4K | 0.00% | −166−0.7% | Reduced |
| Morgan Stanley | 27,914 | $215.5K | 0.00% | +10,353+59.0% | Added |
| Goldman Sachs Group Inc | 30,857 | $238.2K | 0.00% | +368+1.2% | Added |
| Nuveen Asset Management, LLC | 31,729 | $245.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 32,848 | $254.0K | 0.00% | +6,615+25.2% | Added |
| Walleye Capital LLC | 34,117 | $263.4K | 0.01% | +34,117 | New |
| Two Sigma Advisers, LP | 40,975 | $316.3K | 0.00% | −24,200−37.1% | Reduced |
| JPMorgan Chase & Co | 48,149 | $372.0K | 0.00% | +33,919+238.4% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 54,237 | $418.7K | 0.00% | −4,071−7.0% | Reduced |
| Charles Schwab Investment Management Inc | 67,266 | $519.3K | 0.00% | +2,770+4.3% | Added |
| Bank of New York Mellon Corp | 71,806 | $554.3K | 0.00% | −11,785−14.1% | Reduced |
| HighVista Strategies LLC | 90,287 | $697.0K | 0.57% | +90,287 | New |
| Dimensional Fund Advisors LP | 139,672 | $1.08M | 0.00% | +40,865+41.4% | Added |
| Northern Trust Corp | 193,987 | $1.50M | 0.00% | +2,415+1.3% | Added |
| Sphera Funds Management Ltd. | 200,000 | $1.54M | 0.33% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 200,000 | $1.54M | 0.58% | +200,000 | New |
| Affinity Asset Advisors, LLC | 247,891 | $1.91M | 0.74% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 253,069 | $1.95M | 0.38% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 330,294 | $2.55M | 0.00% | −2,600−0.8% | Reduced |
| State Street Corp | 346,671 | $2.68M | 0.00% | +43,253+14.3% | Added |
| Geode Capital Management, LLC | 556,207 | $4.29M | 0.00% | +70,457+14.5% | Added |
| BVF Inc | 858,339 | $6.63M | 0.24% | −277,601−24.4% | Reduced |
| Avidity Partners Management LP | 989,500 | $7.64M | 0.25% | −38,700−3.8% | Reduced |
| Artal Group S.A. | 1,193,030 | $9.21M | 0.55% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 1,202,000 | $9.28M | 1.34% | −23,000−1.9% | Reduced |
| Commodore Capital LP | 1,325,000 | $10.2M | 1.56% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,369,709 | $10.6M | 0.00% | +9,206+0.7% | Added |
| BlackRock Inc. | 1,552,920 | $12.0M | 0.00% | +116,060+8.1% | Added |
| Omega Fund Management, LLC | 2,029,580 | $15.7M | 10.22% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 2,317,634 | $17.9M | 1.70% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $23.1M | 1.67% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 3,136,173 | $24.2M | 20.18% | +10,000+0.3% | Added |
| Great Point Partners LLC | 3,740,761 | $28.9M | 5.71% | +103,043+2.8% | Added |
| OrbiMed Advisors LLC | 4,081,592 | $31.5M | 0.62% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,688,115 | $36.2M | 0.82% | +290,747+6.6% | Added |
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $51.8M | 20.89% | 00.0% | Unchanged |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −181,886−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −30,924−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,204−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −16,763−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −4,453−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1,714−100.0% | Sold out |
| Tradewinds Capital Management, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |